Tiltan Pharma

Develops therapeutics for treatment of metastatic pancreatic cancer using combinatorial drug therapy technology

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2006 language tiltanpharma.com

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Private equity133%
Coming soon